2022 Symposium Agenda

Medicinal Cannabis and Cannabinoid-Based Medicine:
Progress, Policy, and Partnership

 

PDF of the 2022 CMCR Symposium Program

Day 1: Thursday, April 21, 2022

8:00-8:05 Welcome from the CMCR Director, Igor Grant, MD - LINK to VIDEO

2022 CMCR Symposium Awards

8:05-8:40 Daniele Piomelli, PhD, MD (h.c.) - 2022 CMCR Pioneer in Medicinal Cannabis Research Award

Presentation of Award and Keynote Address - Trekking on the Endocannabinoid Trail - LINK to VIDEO

This award honors leaders in cannabis and cannabinoid research conducting basic and translational research of cannabinoids, other constituents of cannabis, and the endocannabinoid system. The recipient’s work has led to significant advancements in our understanding of the mechanism and physiological effects of cannabinoids and related compounds.

8:40-9:15 Donald Abrams, MD - 2022 CMCR Award for Advancing Cannabis and Cannabinoids as Therapeutics

Presentation of Award and Keynote Address - Conducting Clinical Cannabis Research Tribulations and Trials - LINK to VIDEO

This award honors those whose work has led to significant changes in our knowledge of or an expansion to the therapeutic use of cannabis and cannabinoid-based medicines. Recipients come from a diverse array of backgrounds, including drug development, medicine, public policy, and advocacy.

9:15-9:20 5-minute break

9:20-9:55 Moderated panel discussion and Q&A with 2022 CMCR Symposium Award Recipients & previous award recipients - LINK to VIDEO

2022 Award Recipients: Daniele Piomelli, PhD and Donald Abrams, MD

2019 Award Recipients: Raphael Mechoulam, PhD and Geoffrey Guy, MD

9:55-10:00 5-minute break

CMCR Special Lecture

10:00-10:20 Raphael Mechoulam, PhD - Endogenous Anandamide-like Compounds - LINK to VIDEO

10:20-10:30 Q&A moderated by Igor Grant, MD

Panel 1: Update on Federal activities affecting cannabis research - LINK to VIDEO

10:30-11:55 Panel discussion and Q&A moderated by Steve Gust, PhD, Advisor to CMCR

The invited Federal stakeholders will discuss future directions in regulatory policy related to medicinal cannabis, funding for medicinal cannabis research, and access to cannabis and cannabinoids for research purposes.

Panelists:

Trelaine Ito, Deputy Appropriations Director and Legislative Assistant to Senator Schatz - "Congressional Actions Related to Cannabis Affecting Research"

David Shurtleff PhD, National Center on Complementary and Integrative Health (NCCIH), NIH - "Cannabinoid Research at NIH"

Cassandra Taylor PhD, Center for Drug Evaluation and Research, FDA - "FDA Role in Regulation of Cannabis"

Rik Kline PhD, Chief, Chemistry and Pharmaceutics Branch, NIDA - "Role of the NIDA Drug Supply Program in Providing Cannabis Products for Research"

11:55-12:00 5-minute break

12:00-1:00 Poster Session - LINK to pre-recorded VIDEOS

 


Day 2: Friday, April 22, 2022

State of the Science Lecture Series

Welcome - LINK to VIDEO

Neuroprotective Effects of Cannabis and Cannabinoids: Evidence from PTSD - LINK to VIDEO

8:00-8:15 Leah Mayo, PhD - Protective Effects of Elevated Anandamide During Stress Exposure

8:15-8:30 Christine Rabinak, PhD - Cannabinoid Modulation of Corticolimbic Activation to Threat

8:30-8:45 Marcel Bonn-Miller, PhD - Cannabis and PTSD

8:45-8:55 Q&A moderated by Arpi Minassian, PhD

8:55-9:00 5-minute break

Cannabinoids and COVID-19 - LINK to VIDEO

9:00-9:15 Michelle Sexton, ND - Cannabis and COVID-19 Infection

9:15-9:30 José Alexandre S. Crippa, MD, PhD - Cannabidiol (CBD) and COVID-19

9:30-9:40 Q&A moderated by Ajay Bharti, MD

FAAH inhibitor in the Treatment of Substance Use Disorders - LINK to VIDEO

9:40-9:55 Deepak D'Souza, MD - Blunting Cannabis Use Disorder by Targeting the Endocannabinoid System

9:55-10:00 Q&A moderated by Giordano de Guglielmo, PharmD, PhD

10:00-10:05 5-minute break

Panel 2: Promoting industry and university partnership to enhance cannabis research - LINK to VIDEO

10:05-10:55 Panel discussion and Q&A moderated by Igor Grant, MD

Panelists will be invited to discuss partnerships between universities and the cannabis industry, providing models and exploring synergies.

Panelists: Mahmoud ElSohly PhD, Josh Hoerner PhD, Mark Ware MBBS, MRCP, MSc ICD.D

10:55-11:00 5-minute break

Panel 3: Early experience of federally-licensed cannabis growers - LINK to VIDEO

11:00-11:45 Panel discussion and Q&A moderated by Tom Marcotte, PhD

Representatives from DEA-licensed cannabis growers will discuss their early experience and future goals to produce cannabis and cannabinoid-based products for research.

Panelists: Justin Abril (Royal Emerald Pharmaceuticals), Steve Groff MD (Groff North America), George Hodgin MBA (Biopharmaceutical Research Company), Sue Sisley MD (Scottsdale Research Institute)

11:45-12:00 Closing Remarks from the CMCR Director, Igor Grant, MD - LINK to VIDEO